Biblio

Author Title [ Type

] Year

Filters: Author is Kumar, Pankaj [Clear All Filters]

Journal Article

Kumar SK, Jacobus SJ, Cohen AD, Weiss M, Callander N, Singh AK, Parker TL, Menter A, Yang X, Parsons B, et al. Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomise. Lancet Oncol. 2020.

Petrus-Reurer S, Winblad N, Kumar P, Gorchs L, Chrobok M, Wagner AKathleen, Bartuma H, Lardner E, Aronsson M, Reyes APlaza, et al. Generation of Retinal Pigment Epithelial Cells Derived from Human Embryonic Stem Cells Lacking Human Leukocyte Antigen Class I and II. Stem Cell Reports. 2020.

Panula S, Kurek M, Kumar P, Albalushi H, Sánchez SPadrell, Damdimopoulou P, Olofsson JI, Hovatta O, Lanner F, Stukenborg J-B. Human induced pluripotent stem cells from two azoospermic patients with Klinefelter syndrome show similar X chromosome inactivation behavior to female pluripotent stem cells. Hum Reprod. 2019.

Krug S, Gupta M, Kumar P, Feller L, Ihms EA, Kang BGu, Srikrishna G, Dawson TM, Dawson VL, Bishai WR. Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide. Nat Commun. 2023;14(1):8161.

Rana I, Kataria S, Tan TLin, Hajam EYousaf, Kashyap DKumar, Saha D, Ajnabi J, Paul S, Jayappa S, Ananthan AShp, et al. MINDIN (SPONDIN-2) IS ESSENTIAL FOR CUTANEOUS FIBROGENESIS IN A MOUSE MODEL OF SYSTEMIC SCLEROSIS. J Invest Dermatol. 2022.